MBBS, Fellow Hbpathies (UCL, LONDON)
FOUNDER, CEO AMTF (PAK) PROJECT
HEAD FUTURE VISION SUNDUS (PAK)
HCSM Healthcare System Management MCPS
Nationality: Pakistan
info@afzaalfoundation.org
Dr. Asim Qidwai is the first Pakistani Physician who has earned a specialized Master in Haemoglobinopathy from University College London, UK. Dr. Qidwai has a special interest in Benign Hematology and is working in pediatric Haem- oncology for the last 15 years. In 2003 he established AMTF- Helping Blood Disorder, a clinical setup which has been providing total free of cost clinical care the sufferers of blood diseases, primarily focusing in Beta Thalassemia. Dr. Asim Qidwai did his medical school in 1995 followed by residency in pediatric medicine, a fellowship in pediatric hematology and oncology, and a Masters in Haemoglobinopathies from University College London. In 2014 Dr. Qidwai was awarded with a Gold Medal for his services in the establishment of Pakistan’s first intensive care unit for children suffering from blood diseases and cancers and South Asia Triple Helix Award in 2018. Recently received Child welfare award 2019 from 3G Global award from IFA Cambridge.
Present commitments
- CEO – Afzaal Memorial Thalassemia Foundation
- Project Head – Future Vision Sundus Foundation
- Project Head – private public partner shikarpur Thalassemia centre RBUT
- Consultant Advisor USAID – Health Oxygen Echo System Advisor
Last 2 years projects 2021-2022
- Establishment of Amtf shikarpur thalassemia centre as private public partnership with Government of sind now operational with 200 registered patients.
- Consultant Assessment Advisor-CCN (LOCAL) SHORT-TERM CONSULTANT AGREEMENT. Three months project for Tharparkar District. (24th April 2022- 23rd July 2022). Under Chemonics’ contract agreement with the U.S. Agency for International Development (“USAID”) for the USAID (“GHSC-PSM”).
Contributions
ACADEMICS & RESEARCH
- Dr. Qidwai not only has been providing clinical, theoretical and management leadership to his team and patients but he also has been part of many academic activities and research papers. “Endocrinal Complications in Thalassaemia: Frequency and association with serum ferritin levels”. Heema Satwani, Jamal Raza, M. Alam, Asim Qidwai; Pak Paed J. 20015; 29 (3) 113-19.
- “Zinc Status and its Correlation with Basic Parameters in Transfusion Dependent Thalassemia Patients: A Pakistani Perspective”. Sultan S., Irfan SM., Kaker JU., Zeeshan R., Kidwai A. IJBC 2014; (3), 113-118.
- “Assessing Parental Knowledge about Thalassemia in a Thalassemia Center of Karachi, Paksitan”. Humaira Maheen, Farrukh Malik, Barerah Siddiqui, Asim Qidwai; J. Genet Counsel. DOI: 10.1007/s10897-015-9830-z o Trends of red cell alloimmunization in Beta Thalassemia Major Patients: A single center retrospective study in Karachi”. Asim Qidwai, Neelam Mansoor, Anwari Syeda, humaira Maheen, Irfan M., Farrukh Malik; J Blood Disord Treat. 2018; 1(1):3-5.
- “Thalassemia Major: A study on the perception of parents about disease”. Qidwai Asim, Neelam M. Appoo A, Anwari S.; Int J. Blood Dis Dis., 2017; 1(1): 013-015.
- “Saving a Life In Front of my Eyres”. Qidwai et al., J. Blood Disord Transfus, 2017, 8:3. DOI: 10.4172/2155-9864.1000385
Awards & Acknowledgement
- WINNER-3G AWARDS 2019 in CHILDREN WELFARECATEGORY:As a Project Head of Pakistan’s First Free of Cost ICU for Paeds Haem/Onco, Dr. Qidwai has won this international award of The Good Global Governance Award by Cambridge IFA in the year 2019.
Reference - 2014: Dr. Qidwai awarded with Gold Medal for establishing of Pakistan’s first intensive care unit for Blood diseases and Cancers from the Commissioner in Karachi in 2014-2015.
- 2016: AMTF has won Engro I AM THE CHANGE award against the Multi disciplinary Care Approach, Free of Cost services and state-of-the-art Intensive Care Unit by AMTF.
- 2017: AMTF under leadership of Dr. Qidwai has succeeded 6th International Corporate Social Responsibility Award by The professionals Network & Ethical Business Update for overall performance.
- 2017: Dr .Qidwai has been awarded with SATHA Innovation Award for SALIFOME. SATHA Innovation Award is an international award by South Asia Triple Helix Association as Part of International Triple Helix Association.
Pediatric Internship and Residency training details
- Pediatric medicine Internship: 1995-1996, Liaqat National Post Graduate Hospital.
- Pediatric medicine Internship: 1996, Aga Khan , University Hospital.
- Pediatric medicine Internship: 1996, Aga Khan , University Hospital.
- Pediatric residency Cardiology: 1997, Liaqat National Post Graduate Hospital.
- Pediatric residency General Pediatrics and Neoenatology: 1997-1999, Ziauddin Medical University Hospital.
- Residency in Haemoglobinopathies: 1999, Burhani Blood Bank and Transfusion Centre.
- Pediatric Haematology and Oncology: 1997-1999, Ziauddin Medical University Hospital.
- Pediatric Hamatology and Oncology: 1999- 2003, Children Cancer Hospital Pakistan Trust.
Pediatric Haematology and Oncology Services as Specialist
- Thalassemial pratice 2003 – present , AMTF
- Associate Specalist Children Cancer Hospital & Indus Cancer Hospital : ( 2003 – 2016 ).
- Thalassemia Project Incharge Burhani Blood Bank: ( 2001 – 2009 ).
- Advisory New project : Noor Foundation, Jamila Sultana , Klarkaar Vonhaar Hospital .
Membership:
- Pakistan medical and Dental Council- PMDC NUMBER: 28454 – P
- University College London Hospital- UCL NUMBER: 935162/1
- European Hematology Association- EHA Number: 011051
- Member of American Society of Microbiology
- Member of Canadian Blood Transfusion Society
- Member of the International Society of Hemostasis and Thrombosis & European Hematology Association